Researcher.Life Logo

Journal of Cardiovascular Pharmacology : Impact Factor & More

eISSN: 1533-4023pISSN: 0160-2446

Key Metrics

CiteScore
3.7
Impact Factor
< 5
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Cardiovascular Pharmacology

Journal of Cardiovascular Pharmacology Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1979
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Cardiovascular Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Cardiovascular Pharmacology

Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment Strategies for Patients With Significant Left Anterior Descending Artery Disease (COMMIT-LAD).
  • 1 May 2026
  • Journal of cardiovascular pharmacology
The Multifaceted Role of Angiopoietin-Like Proteins in Coronary Heart Disease: From Molecular Mechanisms to Clinical Translation.
  • 1 May 2026
  • Journal of cardiovascular pharmacology
Rivaroxaban safety and adherence in patients with nonvalvular atrial fibrillation: prospective, observational, cohort, postmarketing study.
  • 21 Apr 2026
  • Journal of cardiovascular pharmacology
Mean Platelet Volume Shows Distinct Patterns Between Mitral and Aortic Valve Replacement Patients but Does Not Predict Anticoagulation Quality in Mechanical Heart Valves.
  • 21 Apr 2026
  • Journal of cardiovascular pharmacology
Sonodynamic Therapy Attenuates TLR4/NF-κB Signaling in Epicardial Adipose Tissue of Atrial Fibrillation: Insights from Animal Models, scRNA-seq, and Mendelian Randomization.
  • 9 Apr 2026
  • Journal of cardiovascular pharmacology
Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study
  • 8 Apr 2026
  • Journal of Cardiovascular Pharmacology
Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment Strategies for Patients With Significant Left Anterior Descending Artery Disease (COMMIT-LAD).
  • 1 May 2026
  • Journal of cardiovascular pharmacology
The Multifaceted Role of Angiopoietin-Like Proteins in Coronary Heart Disease: From Molecular Mechanisms to Clinical Translation.
  • 1 May 2026
  • Journal of cardiovascular pharmacology
Rivaroxaban safety and adherence in patients with nonvalvular atrial fibrillation: prospective, observational, cohort, postmarketing study.
  • 21 Apr 2026
  • Journal of cardiovascular pharmacology
Mean Platelet Volume Shows Distinct Patterns Between Mitral and Aortic Valve Replacement Patients but Does Not Predict Anticoagulation Quality in Mechanical Heart Valves.
  • 21 Apr 2026
  • Journal of cardiovascular pharmacology
Sonodynamic Therapy Attenuates TLR4/NF-κB Signaling in Epicardial Adipose Tissue of Atrial Fibrillation: Insights from Animal Models, scRNA-seq, and Mendelian Randomization.
  • 9 Apr 2026
  • Journal of cardiovascular pharmacology
Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study
  • 8 Apr 2026
  • Journal of Cardiovascular Pharmacology

FAQs on Journal of Cardiovascular Pharmacology